Cannabis Science Inc (OTCMKTS:CBIS) has issued a growth guidance and update on its future plans. It should be noted here that the update has been issued, after carefully analyzing market and industry trends, the changes in legislations.
Cannabis Science Inc (OTCMKTS:CBIS) has let down its shareholders again. For the first two months of this year, we've been watching CBIS and thought that in spite of past broken promises, the company might be due for a bounce.
The string of press releases coming from Cannabis Science Inc (OTCMKTS:CBIS) is no longer a laughing matter. We would hope that as a public company CBIS would work as hard to complete its annual report as it does on issuing non-stop press releases.
Cannabis Science Inc (OTCMKTS:CBIS) saw a massive surge of volume and price starting Monday when the entire pot stock sector got a huge boost after GW Pharmaceuticals announced positive Phase 3 trial data for its drug Epidiolex, for the treatment of ...
Cannabis Science, Inc. (the “Company”) wishes to update its current and former shareholders regarding the previously approved share dividend, which was filed on a Definitive Schedule 14C with the Commission on August 18, 2011.
Cannabis Science Inc (OTCMKTS:CBIS) has been moving up steadily in recent days on heavy trading volume. The stock is one of the original pot stocks on the OTC with a long history of huge moves every time the sector moves up.